Trial intelligence / Profile preview

Praziquantel therapy for Schistosoma mansoni infection in preschool-aged children

PACTR202008871179105Unknown

Sponsor
CDT Africa
Start
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of praziquantel in schistosomiasis, sponsored by CDT Africa. Primary endpoint: cure rate. Status: unknown.

02

Drugs

praziquantel
03

Conditions

schistosomiasis

Beyond the preview

Go deeper on PACTR202008871179105.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202008871179105.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call